Details.
A study investigating an experimental new medicine for problems with thinking such as memory and concentration, linked to brain disorders like Alzheimer's disease and schizophrenia. For healthy male or female participants aged 18 to 55 with a BMI of 18 to 30.9 kg/m2. Participation involves 2 to 4 nights and at least 2 clinical visits. Study payment is £1,250 to £2,315.